Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor, Adult × Panitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 96 Colonic Neoplasms 28 Neoplasm Metastasis 26 Rectal Neoplasms 25 Neoplasms 21 Carcinoma, Non-Small-Cell Lung 13 Esophageal Neoplasms 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 7 Cholangiocarcinoma 6 Carcinoma, Squamous Cell 6 Breast Neoplasms 6 Colorectal Cancer Metastatic 5 Carcinoma 5 Recurrence 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Triple Negative Breast Neoplasms 3 Gastrointestinal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Kidney Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Advanced Solid Tumors 2

Interventions

pembrolizumab 6 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Valganciclovir 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡